New women’s health biotech KaNDy Therapeutics—rumored to have attracted buyout interest from Allergan—has just reported data on its lead product that could enhance its allure.
This content was originally published here.
Health and Wellness
A Turning Point for Menopause Care: FDA Panel Urges Reform on Hormone Therapy Warnings
On July 17, 2025, the U.S. Food and Drug Administration (FDA) hosted a landmark expert panel to address longstanding controversies surrounding hormone replacement therapy (HRT)
